TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Aurena Laboratories Holding AB
Closing information (x1000 EUR)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 19,787 | 18,958 | 16,491 |
Financial expenses | 148 | 92 | 62 |
Earnings before taxes | 1,238 | 995 | 896 |
EBITDA | 1,858 | 1,612 | 1,326 |
Total assets | 17,737 | 16,733 | 15,062 |
Current assets | 8,164 | 6,928 | 6,265 |
Current liabilities | 4,791 | 3,145 | 2,800 |
Equity capital | 9,355 | 9,311 | 8,811 |
- share capital | 45 | 49 | 50 |
Employees (average) | 76 | 76 | 74 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 52.7% | 55.6% | 58.5% |
Turnover per employee | 260 | 249 | 223 |
Profit as a percentage of turnover | 6.3% | 5.2% | 5.4% |
Return on assets (ROA) | 7.8% | 6.5% | 6.4% |
Current ratio | 170.4% | 220.3% | 223.8% |
Return on equity (ROE) | 13.2% | 10.7% | 10.2% |
Change turnover | 2,365 | 2,772 | -4,834 |
Change turnover % | 14% | 17% | -23% |
Chg. No. of employees | 0 | 2 | 1 |
Chg. No. of employees % | 0% | 3% | 1% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.